Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation
about
Mineral and bone disorder after kidney transplantationVitamin D in renal transplantation - from biological mechanisms to clinical benefitsAntidepressants differentially related to 1,25-(OH)₂ vitamin D₃ and 25-(OH) vitamin D₃ in late-life depression.Impact of seasonality on the dynamics of native Vitamin D repletion in long-term renal transplant patientsThe use of fibroblast growth factor 23 testing in patients with kidney disease.Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart FailureCalcification Propensity and Survival among Renal Transplant Recipients.Fibroblast growth factor-23 and chronic allograft injury in pediatric renal transplant recipients: a Midwest Pediatric Nephrology Consortium study.Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study.Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy.Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.Vitamin D: a new player in kidney transplantation?Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease.Bone kidney interactions.The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder.Phosphate and FGF-23 homeostasis after kidney transplantation.Post-Transplant Hypophosphatemia and the Risk of Death-Censored Graft Failure and Mortality after Kidney Transplantation.Fibroblast Growth Factor 23: Mineral Metabolism and Beyond.Hyperparathyroidism and increased fractional excretion of phosphate predict allograft loss in long-term kidney transplant recipients.Extrarenal effects of FGF23.C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients.Fibroblast growth factor 23 correlates with volume status in haemodialysis patients and is not reduced by haemodialysis.FGF23 in kidney transplant: the strange case of Doctor Jekyll and Mister Hyde.The fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk.Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.The Association Between Fibroblast Growth Factor 23 and Renal Transplantation Outcome Is Modified by Follow-up Duration and Glomerular Filtration Rate Assessment Method.Long-Term Progression of Coronary Artery Calcification Is Independent of Classical Risk Factors, C-Reactive Protein, and Parathyroid Hormone in Renal Transplant Patients.Tubular maximum phosphate reabsorption capacity in living kidney donors is independently associated with one-year recipient GFR.Evaluation of a New Fully Automated Assay for Plasma Intact FGF23.Baseline FGF23 is Associated with Cardiovascular Outcome in Incident PD Patients.Plasma levels of marine n-3 fatty acids and cardiovascular risk markers in renal transplant recipients.Membrane-bound Klotho is not expressed endogenously in healthy or uraemic human vascular tissue.Paracrine Effects of FGF23 on the Heart.Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation.
P2860
Q26771398-C7B6FFF7-3BDF-43BC-BAC9-BC2240EC8C6CQ27026932-B51F468D-8A7F-40E7-869C-2BE0D52A9F4EQ33574994-8D59A8B8-6A7E-4B46-A6E0-A7F3DD87C5ADQ33783035-DFC0B313-0ECA-484A-80EC-95F6382F83C7Q33835743-E3BDBF1B-FA19-4636-A48C-65CDE3C8F2EFQ35665003-5DBBBF97-1B8B-4997-B32D-FBD86DEF42A9Q36417860-94E8D547-91C6-4690-BC68-CEAAB9912674Q36759150-3149BF0C-A01A-4261-A9A2-96108AF146AEQ37240698-B58E3974-F0ED-4E2B-9F89-3605645013F9Q37432867-72A90BB4-16A2-4507-A854-DB802D929AECQ38200883-E7C79EC6-17DC-4C7A-9470-061B7C82CA5CQ38241062-80DFA327-5519-4D04-8135-B72D71446081Q38249494-F0F3D209-2E77-4B08-9D1D-CED168DB1FECQ38544166-B7625479-97A1-4923-ADFB-BBCB2BE57072Q38584122-25323739-B740-4311-B0DB-BD8C101D34FAQ38594874-90A55FCA-369C-47C6-9EEE-8366DA4618DAQ38762820-43572C54-2760-47B1-851A-0F4181D30D69Q38768746-26B1C099-211B-4BE1-AD1A-505C0A7C7331Q38782222-ACD746F6-74A0-4FEA-BF40-6E56F446A90EQ38972469-DB0CFF90-F2FB-405B-9A5D-E341218A65D1Q40095461-3A0D0AA6-E289-42C3-8889-5DA25250BD1CQ40279706-4AB5F7A1-BE81-47DE-9025-167D2149C0F9Q41186366-12E6DD6E-FF3D-47DF-BA11-2F4B4AAACEFBQ45134043-C7887F68-4935-439C-8BCB-E1204DBE36DDQ47134765-6B4EA2E7-331B-4835-AEA5-0CE45BFD2D0EQ47151319-CF360089-414E-426B-991B-685ABEE3A97DQ47423230-60E68152-313B-4417-B153-243E7519CE7EQ47863864-C899A149-A39F-43AD-AD0F-144ACC1770BFQ48316515-741F79BD-3E4E-42D3-B3E3-ECEC95023E48Q50636871-0C43B28B-1D5B-4F02-B820-73F79B3F8C92Q51287889-56E61ADC-2958-49F8-8476-166662A9ABB7Q52934731-1D412442-25F1-48AF-93D9-C65DD94586AAQ55221465-835BECD8-BDF5-4B5E-B71A-5976BACD346EQ55496554-A3FC63F8-E4A0-48F0-806D-6F1835F48B11
P2860
Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation
@en
Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation.
@nl
type
label
Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation
@en
Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation.
@nl
prefLabel
Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation
@en
Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation.
@nl
P2093
P2860
P356
P1476
Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation
@en
P2093
Gerjan Navis
Jelmer K Humalda
Leandro C Baia
Marc G Vervloet
Martin H de Borst
NIGRAM Consortium
Stephan J L Bakker
P2860
P304
P356
10.2215/CJN.01880213
P577
2013-08-08T00:00:00Z